Profound Net Income From Continuing Ops from 2010 to 2026
| PRN Stock | CAD 8.90 0.40 4.71% |
Net Loss | First Reported 2018-06-30 | Previous Quarter -15.7 M | Current Value -8 M | Quarterly Volatility 2.4 M |
Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 718 K or Selling General Administrative of 27.9 M, as well as many indicators such as Price To Sales Ratio of 29.06, Dividend Yield of 0.0 or PTB Ratio of 3.89. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
Profound | Net Income From Continuing Ops |
Evaluating Profound Medical's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Profound Medical Corp's fundamental strength.
Latest Profound Medical's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Profound Medical Corp over the last few years. It is Profound Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Profound Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (21,356,136) | |
| Coefficient Of Variation | (24.96) | |
| Mean Deviation | 4,612,067 | |
| Median | (20,192,250) | |
| Standard Deviation | 5,330,774 | |
| Sample Variance | 28.4T | |
| Range | 14.4M | |
| R-Value | (0.87) | |
| Mean Square Error | 7.5T | |
| R-Squared | 0.75 | |
| Slope | (915,698) | |
| Total Sum of Squares | 454.7T |
Profound Net Income From Continuing Ops History
About Profound Medical Financial Statements
Profound Medical investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Profound Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -25 M | -26.3 M |
Pair Trading with Profound Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Profound Stock
| 0.67 | ATH | Athabasca Oil Corp | PairCorr |
| 0.47 | GFL | Gfl Environmental | PairCorr |
| 0.44 | PNC-B | Postmedia Network Canada | PairCorr |
The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.
The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Profound Medical Correlation against competitors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.